Kamuvudine-9在新型实验性孔源性视网膜脱离模型中保护视网膜结构与功能
在小鼠经视网膜下注射1%羧甲基纤维素诱导的孔源性视网膜脱离(RRD)及自发复位(RRD/SRR)模型中,腹腔注射Kamuvudine-9(K-9)、拉米夫定(3TC)或齐多夫定(AZT)均抑制视网膜炎症小体激活和光感受器死亡;K-9在RRD期间保护视网膜电功能,并在视网膜复位后诱导功能改善。
要点
- 小鼠RRD诱导视网膜炎症小体激活和光感受器死亡。
- K-9、3TC或AZT全身给药均抑制视网膜炎症小体激活和光感受器死亡。
- 在RRD/SRR模型中,K-9保护RRD期间的视网膜电功能并在复位后改善功能。
核心结论
- K-9和NRTIs在实验性RRD中表现出抗炎和神经保护活性。
- 鉴于K-9在RRD期间保护光感受器功能并增强复位后视网膜功能的能力,K-9显示出作为视网膜神经保护剂的希望,并值得在RRD中开展研究。
- 这种新型RRD/SRR模型可能有助于对RRD相关功能结局进行实验评估。
研究设计与样本
- 在小鼠中通过视网膜下注射1%羧甲基纤维素(CMC)诱导RRD。
- 为模拟RRD临床管理后的结局,确定CMC视网膜下注射诱导自发视网膜复位(SRR)在10天内发生的最佳条件(RRD/SRR)。
- K-9、3TC或AZT通过腹腔注射给药。
- 通过裂解型caspase-1、IL-18和裂解型caspase-8的丰度监测炎症小体激活通路,通过TUNEL染色评估光感受器死亡。
- 通过全视野暗适应视网膜电图评估视网膜功能。
主要发现
- RRD在小鼠中诱导视网膜炎症小体激活和光感受器死亡。
- K-9、3TC或AZT全身给药抑制视网膜炎症小体激活和光感受器死亡。
- 在RRD/SRR模型中,K-9在RRD期间保护视网膜电功能,并在视网膜复位后诱导功能改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Rhegmatogenous retinal detachment (RRD) is a vision-threatening event that benefits from surgical intervention. While awaiting surgical reattachment, irreversible hypoxic and inflammatory damage to the retina often occurs. An interim therapy protecting photoreceptors could improve functional outcomes. We sought to determine whether Kamuvudine-9 (K-9), a derivative of nucleoside reverse transcriptase inhibitors (NRTIs) that inhibits inflammasome activation, and the NRTIs lamivudine (3TC) and azidothymidine (AZT) could protect the retina following RRD. METHODS: RRD was induced in mice via subretinal injection (SRI) of 1% carboxymethylcellulose (CMC). To simulate outcomes following the clinical management of RRD, we determined the optimal conditions by which SRI of CMC induced spontaneous retinal reattachment (SRR) occurs over 10 days (RRD/SRR). K-9, 3TC, or AZT was administered via intraperitoneal injection. Inflammasome activation pathways were monitored by abundance of cleaved caspase-1, IL-18, and cleaved caspase-8, and photoreceptor death was assessed by TUNEL staining. Retinal function was assessed by full-field scotopic electroretinography. RESULTS: RRD induced retinal inflammasome activation and photoreceptor death in mice. Systemic administration of K-9, 3TC, or AZT inhibited retinal inflammasome activation and photoreceptor death. In the RRD/SRR model, K-9 protected retinal electrical function during the time of RRD and induced an improvement following retinal reattachment. CONCLUSIONS: K-9 and NRTIs exhibit anti-inflammatory and neuroprotective activities in experimental RRD. Given its capacity to protect photoreceptor function during the period of RRD and enhance retinal function following reattachment, K-9 shows promise as a retinal neuroprotectant and warrants study in RRD. Further, this novel RRD/SRR model may facilitate experimental evaluation of functional outcomes relevant to RRD.
引用
- Huang P, Thomas CC, Ambati K, et al. Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal Detachment. Invest Ophthalmol Vis Sci. 2023. PMID: 37129905. doi:10.1167/iovs.64.5.3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。